ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2025
Assessment of knowledge and awareness about ovarian cancer and its risk factors among women in Jazan, Saudi Arabia: a cross-sectional study.
Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies.Journal of cellular and molecular medicine · 2026Article
- Ovarian cancer and healthy lifestyle awareness among women of reproductive age.BMC women's health · 2025Article
- Awareness of magnetic resonance imaging for early detection of breast cancer: A cross-sectional study.The Journal of international medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Ovarian cancer (OC) is the fourth leading cancer form in Jazan, Saudi Arabia. However, limited awareness and delayed healthcare-seeking behaviors might negatively impact screening uptake and early diagnosis. This study aimed to assess awareness and knowledge of OC, and related risk factors among the female population of Jazan region, Saudi Arabia. A cross-sectional web-based survey was conducted asking questions about the general awareness, knowledge, and awareness of risk factors associated with OC using a self-administered questionnaire. Descriptive statistics, chi-square tests, and Pearson's correlation analysis were used to analyze the data and a p ≤ 0.05 was considered statistically significant. Of the 465 participants, 433 completed the questionnaire (response rate = 93%). Internal reliability of questionnaire sections was found acceptable (Cronbach's alpha = 0.794, 0.738, and 0.816). Alarmingly, a significant majority of respondents exhibited poor general awareness (85%), poor knowledge (89.1%), and poor awareness of risk factors (86.1%). Only a small tested population showed good to moderate awareness (14.9%), knowledge (10.9%), and awareness of risk factors (13.8%). Significant positive correlations were observed between OC awareness and knowledge (r = 0.60, p < 0.01), OC awareness and risk factor awareness (r = 0.515, p < 0.01), as well as between knowledge and risk factor awareness (r = 0.634, p < 0.01). Limited awareness of OC and its risk factors were noted in the women population of Jazan region which highlights the importance and critical need for targeted educational initiatives aimed to improve the general public understanding and to promote preventive and screening measures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.